# Risk of Malignant Neoplasia with Glucagon-Like Peptide-1 Receptor Agonist Treatment in Patients with Type 2 Diabetes: A Meta-Analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/risk-of-malignant-neoplasia-with-glucagon-like-peptide-1-receptor-agonist/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yufang Liu,Xiaomei Zhang,Sanbao Chai,Xin Zhao,Linong Ji |
| Citations | 47 |
| DOI | 10.1155/2019/1534365 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://downloads.hindawi.com/journals/jdr/2019/1534365.pdf |
| OpenAlex ID | https://openalex.org/W2959708126 |
| PMID | 31396537 |
| Type | review |
| Year | 2019 |

## Paper authors

- [Xin Zhao](https://scholariq.org/researchers/xin-zhao/)

## Paper journal

- [Journal of Diabetes Research](https://scholariq.org/journals/journal-of-diabetes-research/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.